Writer vs Google DeepMind
Side-by-side trajectory, velocity, and editorial themes.
Writer is building the buyer-side ecosystem around its enterprise AI agents.
Recent moves cluster around making Writer the default platform for enterprise marketing teams running AI agents — an AI Academy opened to all users with a Passport curriculum and credentials, a newly launched AI CMO Council for senior buyers, and WRITER Agent connectors to FRED, OECD, World Bank, and SEC EDGAR for citation-grade research. The feed itself is heavy on thought leadership and customer storytelling alongside the actual product news.
Writer is investing on the buyer side of the agent platform — credentialing for users, peer community for executive buyers, and connector breadth for use cases where citation accuracy matters. Less new core modeling, more making the enterprise AI workflow purchase rationale concrete. The repeated 'agentic marketing' framing across customer stories, thought pieces, and product posts reads as deliberate category positioning.
Expect more vertical data connectors in the FRED/SEC pattern (legal, regulatory, healthcare reference sources), and for AI Academy credentialing to become a sales-enablement asset tied to the CMO Council. The thought-leadership cadence suggests Writer wants to own the enterprise-AI-marketing category narrative before competitors anchor it.
DeepMind is repositioning Gemini as the substrate for scientific research, not just consumer AI.
DeepMind's recent output is dominated by Co-Scientist case studies and the formal launch of a 'Gemini for Science' suite, with applied research wins clustered around biology — aging, ALS, liver disease, infectious disease triggers. A second strand expands consumer-facing tools (Project Genie + Street View) for Google AI Ultra subscribers and pushes on content provenance. National partnership announcements (Singapore) round out the geopolitical surface.
The center of gravity is shifting from frontier model releases to vertical applications, particularly in life sciences. Co-Scientist appears to be moving from internal project to a packaged offering institutions can collaborate on. Consumer features and content authenticity work continue in parallel but feel secondary to the science push.
Expect a formal Co-Scientist productization announcement with institutional access tiers within the next quarter, and additional 'Gemini for X' verticals (likely materials science or drug discovery) to follow the science framing.
See more alternatives to Writer →
See more alternatives to Google DeepMind →